Host cell targets for antiviral therapy:: an update

被引:4
作者
DeFilippis, Victor [1 ]
Frueh, Klaus [1 ]
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA
关键词
cholesterol pathway; endocytosis farnesyl; geranyl-geranyl; Gleevec((R)); small interfering; RNA; statin; therapeutic targets;
D O I
10.2217/17460794.1.4.509
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The discovery of antiviral therpeutic targets has traditionally focussed on conserved viral gene products. Since viruses are obligate molecular parasites requiring and manipulating host cell functions, the identification of host proteins essential to viruses but not cellular survival represent attractive and underutilized targets for antiviral therapies. Numerous studies have identified host cell functions, pathways and proteins that are essential for viral propagation, from entry to replication, assembly and egress. Importantly, several studies demonstrate virus inhibition through nonlethal impairment of host cell function both in vitro and in vivo. In addition, high-throughput experimental platforms allowing global or nearglobal surveillance of host gene products in the context of virus replication are now being used to systematically identify host cell targets. Recent breakthrough studies that have employed such methods successfully to identify host proteins and pathways crucial for virus growth are discussed in this review.
引用
收藏
页码:509 / 518
页数:10
相关论文
共 50 条
[21]   Retroviral vectors and gene therapy: An update [J].
Maurya, S. K. ;
Srivastava, Sushant ;
Joshi, R. K. .
INDIAN JOURNAL OF BIOTECHNOLOGY, 2009, 8 (04) :349-357
[22]   Current Therapy and Therapeutic Targets for Microsporidiosis [J].
Wei, Junhong ;
Fei, Zhihui ;
Pan, Guoqing ;
Weiss, Louis M. ;
Zhou, Zeyang .
FRONTIERS IN MICROBIOLOGY, 2022, 13
[23]   CRISPR-Cas based targeting of host and viral genes as an antiviral strategy [J].
Koujah, Lulia ;
Shukla, Deepak ;
Naqvi, Afsar R. .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2019, 96 :53-64
[24]   In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments [J].
Colomer-Castell, Sergi ;
Gregori, Josep ;
Garcia-Cehic, Damir ;
Riveiro-Barciela, Mar ;
Buti, Maria ;
Rando-Segura, Ariadna ;
Vico-Romero, Judit ;
Campos, Carolina ;
Ibanez-Lligona, Marta ;
Adombi, Caroline Melanie ;
Cortese, Maria Francesca ;
Tabernero, David ;
Esteban, Juan Ignacio ;
Rodriguez-Frias, Francisco ;
Quer, Josep .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
[25]   Virus-specific host miRNAs: antiviral defenses or promoters of persistent infection? [J].
Mahajan, Vinay S. ;
Drake, Adam ;
Chen, Jianzhu .
TRENDS IN IMMUNOLOGY, 2009, 30 (01) :1-7
[26]   Intracellular delivery of antiviral shRNA using penetratin-based complexes effectively inhibits respiratory syncytial virus replication and host cell apoptosis [J].
Faghirabadi, Faezeh ;
Abuei, Haniyeh ;
Malekzadeh, Mohammad Hossein ;
Mojiri, Anahita ;
Farhadi, Ali .
VIROLOGY JOURNAL, 2024, 21 (01)
[27]   Ezetimibe therapy: mechanism of action and clinical update [J].
Phan, Binh An P. ;
Dayspring, Thomas D. ;
Toth, Peter P. .
VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 :415-427
[28]   New molecular targets of breast cancer therapy [J].
Sauer, G ;
Deissler, H ;
Kurzeder, C ;
Kreienberg, R .
STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (03) :123-+
[29]   New Molecular Targets of Breast Cancer Therapy [J].
Georg Sauer ;
Helmut Deissler ;
Christian Kurzeder ;
Rolf Kreienberg .
Strahlentherapie und Onkologie, 2002, 178 :123-133
[30]   Potassium channels:: New targets in cancer therapy [J].
Felipe, Antonio ;
Vicente, Ruben ;
Villalonga, Nuria ;
Roura-Ferrer, Meritxell ;
Martinez-Marmol, Ramon ;
Sole, Laura ;
Ferreres, Joan C. ;
Condom, Enric .
CANCER DETECTION AND PREVENTION, 2006, 30 (04) :375-385